Tech Company Financing Transactions
Cellomics Funding Round
Cellomics closed a $5.3 million financing round on 1/9/2004. Investors included Oxford Bioscience Partners, Alta Partners and Axiom Venture Partners.
Transaction Overview
Company Name
Announced On
1/9/2004
Transaction Type
Venture Equity
Amount
$5,300,000
Round
Undisclosed
Investors
Oxford Bioscience Partners (Lead Investor) (Jonathan Fleming)
Proceeds Purpose
This financing, coupled with the completion of the company's restructuring efforts, which began in early 2002, plus continued revenue growth, makes Cellomics a financially sound, operationally-oriented company, positioning us for profitability in 2004.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
100 Technology Dr.
Pittsburgh, PA 15219
USA
Pittsburgh, PA 15219
USA
Phone
Website
Email Address
Not Recorded
Overview
Cellomics, a business unit within the Fisher Biosciences group, provides complete systems for High Content Screening (HCS) and Analysis (HCA) to drug discovery and systems biology researchers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dan Calvo
Browse more venture capital transactions:
Prev: 1/8/2004: E4X venture capital transaction
Next: 1/12/2004: Metabolex venture capital transaction
Share this article
About Database of VC Transactions
We report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs